Replies to post #102 on Moleculin Biotech Inc (MBRX)

[zino]

Anticipated Milestone Timeframe

Announcement that our IND for Annamycin has become effective and that we may begin clinical trials End of July 2017

IRB (Institutional Review Board) approvals and site initiations of various clinical sites participating in our Phase I/II clinical trial of Annamycin Second Half of 2017

Establishment of a new MTD for Annamycin Second Half of 2017

A clinician sponsored IND for WP1066 for treatment of adult brain tumors moving forward Second Half of 2017

Announcement of Phase II data for Annamycin 2018

Announcement of further benefits of our sponsored research agreement with MD Anderson
https://ih.advfn.com/p.php?pid=nmona&article=74678232

[stock1ace1]

Great call knew i should bought the dip after gap go buddy :)